S
Shirin Jamshidi
Researcher at King's College London
Publications - 38
Citations - 717
Shirin Jamshidi is an academic researcher from King's College London. The author has contributed to research in topics: DNA gyrase & Gene. The author has an hindex of 11, co-authored 37 publications receiving 495 citations. Previous affiliations of Shirin Jamshidi include Pasteur Institute of Iran & Shahid Beheshti University of Medical Sciences and Health Services.
Papers
More filters
Journal ArticleDOI
Experimental diabetes treated with Achillea santolina: effect on pancreatic oxidative parameters.
TL;DR: It can be concluded that Achillea santolina have a high hypoglycaemic activity and this may be attributed to its antioxidative potential.
Journal ArticleDOI
Structure of thermobifida fusca DyP-type peroxidase and activity towards kraft lignin and lignin model compounds
TL;DR: A Dyp-type peroxidase enzyme from thermophilic cellulose degrader Thermobifida fusca (TfuDyP) was investigated for catalytic ability towards lignin oxidation, and showed reactivity towards Kraft lIGNin, and was found to oxidise a β-aryl ether lign in model compound, forming an oxidised dimer.
Journal ArticleDOI
Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
TL;DR: Different bacterial EPIs originating from both natural source and chemical synthesis are discussed and the challenges to designing successful EPIs that can be useful against multidrug resistant bacteria are examined.
Journal ArticleDOI
Cytotoxic Naphthoquinone and Azaanthraquinone Derivatives from an Endophytic Fusarium solani.
N. S. Chowdhury,N. S. Chowdhury,N. S. Chowdhury,Md. Hossain Sohrab,Md. Sohel Rana,Choudhury M. Hasan,Shirin Jamshidi,Khondaker M. Rahman +7 more
TL;DR: Bioactivity-guided fractionation of the ethyl acetate extract obtained from the culture of the endophytic fungus Fusarium solani resulted in the isolation of one new naphthoquinone, 9-desmethylherbarine, and two azaanthraquinone derivatives, 7-des methylscorpinone and 7- Desmethyl-6-methylbostrycoidin, along with four known compounds.
Journal ArticleDOI
Fluoxetine and thioridazine inhibit efflux and attenuate crystalline biofilm formation by Proteus mirabilis.
Jonathan Nzakizwanayo,Paola Scavone,Shirin Jamshidi,Joseph A. Hawthorne,H. Pelling,Cinzia Dedi,Jonathan P. Salvage,Charlotte K. Hind,Fergus M. Guppy,Lara M. Barnes,Bhavik Anil Patel,Khondaker M. Rahman,Mark J. Sutton,Brian V. Jones +13 more
TL;DR: The potential for drugs already used in human medicine to act as EPIs in P. mirabilis and repurposing of existing drugs with EPI activity could be a promising approach to control catheter blockage, or biofilm formation on other medical devices.